6988 J. Am. Chem. Soc., Vol. 119, No. 30, 1997
Okamoto et al.
119.93, 119.52, 108.54, 96.23, 52.98, 36.74, 21.99, 21.18, 17.02; IR
(Nujol) 3380, 2950, 1625, 1325. Anal. Calcd for C13H13NO: C, 78.36;
H, 6.58; N, 7.03. Found: C, 78.33; H, 6.73; N, 6.89.
to these methods, the present synthesis was the shortest (seven
steps) and gave the highest overall yield (27% from N-protected
L-proline). Noteworthy also is the fact that, as deuterolysis of
the reaction mixture of 1 and 24 gave a deuterated compound
26 (>98% D), the present method enables the synthesis of C(10)
deuterium (and probably tritium) labeled allopumiliotoxin 267A.
Pyrrolo[1,2-a]cyclopropa[3,4]pyrrolidin-3-ol (entry 5, Table 1):
1H NMR (300 MHz) δ 6.46 (dd, J ) 3.0, 1.2, 1H), 6.18 (t, J ) 3.0,
1H), 6.00 (dd, J ) 3.4, 1.2, 1H), 4.23 (dd, J ) 11.4, 5.7, 1H), 3.70 (d,
J ) 11.4, 1H), 2.76 (br s, 1H). 2.17 (m, 1H), 1.67 (dd, J ) 9.3, 5.7,
1H), 0.91 (t, J ) 5.3, 1H); 13C NMR (75 MHz) δ 138.48, 113.89,
112.04, 98.35, 61.14, 48.47, 27.48, 23.63; IR (Nujol) 3800, 1580, 1330.
Anal. Calcd for C8H9NO: C, 71.09; H, 6.71; N, 10.36. Found: C,
71.01; H, 7.10; N, 7.39.
Pyrrolo[1,2-a]cyclopropa[3,4]piperidin-3-ol (entry 6, Table 1):
1H NMR (300 MHz) δ 6.51 (dd, J ) 2.6, 1.8, 1H), 6.22 (dd, J ) 3.5,
1.7, 1H), 6.12 (t, J ) 3.2, 1H), 3.88 (ddd, J ) 12.9, 5.9, 1.9, 1H), 3.43
(dt, J ) 4.7, 12.9, 1H), 2.16 (ddt, J ) 3.3, 5.6, 13.0, 1H), 2.00 (m,
1H), 1.64 (m, 1H), 1.30 (dd, J ) 9.9, 6.0, 1H), 1.00 (t, J ) 6.0, 1H);
13C NMR (75 MHz) δ 132.86, 119.08, 107.05, 102.87, 52.95, 40.56,
21.51, 21.04, 16.24; IR (Nujol) 3150, 2890, 1630, 1319. Anal. Calcd
for C9H11NO: C, 72.46; H, 7.43; N, 9.39. Found: C, 71.97; H, 7.61;
N, 9.51.
Procedure for the Reaction of Acetylenic Substrates. To a stirred
solution of N-propargyl- or N-homopropargyl compound 5, 10, or 13
(1.0 mmol) and Ti(O-i-Pr)4 (325 µL, 1.3 mmol) in ether (8-10 mL)
was added i-PrMgCl or i-PrMgBr (1.1-1.7 M in ether, 2.6 mmol) at
-78 °C. The resulting mixture was gradually warmed to -50 °C over
0.5-1 h and stirred for 1-2 h at -50 °C ∼ -40 °C. After addition of
saturated aqueous NaHCO3 (1.0 mL) at -40 °C, the mixture was
warmed to ambient temperature. NaF (2 g) and Celite (2 g) were added,
and the resulting mixture was stirred for 1 h at room temperature. The
mixture was filtered through a pad of Celite, and the filterate was
concentrated in Vacuo. The residue was purified by column chroma-
tography on silica gel to afford the N-heterocycles having a R-alkylidene
ketone moiety.
(E)-1-Benzyl-1,2,3,4-tetrahydro-3-trimethylsilylmethylene-4-qui-
nolone (7a): 1H NMR (300 MHz) δ 8.04 (dd, J ) 1.8, 7.8, 1H), 7.31
(m, 6H), 6.98 (t, J ) 1.8, 1H), 6.75 (m, 2H), 4.54 (s, 2H), 4.24 (d, J
) 1.7, 2H), 0.07 (s, 9H); 13C NMR (75 MHz) δ 189.42, 151.86, 145.91,
138.05, 136.96, 135.49, 129.65, 128.92, 127.44, 127.28, 117.76, 113.12,
54.49, 53.87, -0.74; IR (neat) 2980, 1630, 1583, 1300. Anal. Calcd
for C20H23NOSi: C, 74.72; H, 7.21; N, 4.36. Found: C, 74.61; H,
7.38; N, 4.67.
Conclusion
We have developed a highly efficient method for the
preparation of N-heterocyclic compounds such as quinolone,
indole, and pyrrole derivatives and optically active pyrrolidine
and piperidine derivatives by using the titanium(II)-mediated
INAS or INAS-ICA reaction. The reaction is practical since
the starting organic substrates are readily available. Nontoxic,
inexpensive metallic starting materials are used, and the
procedure is operationally simple. Moreover, the N-heterocycles
obtained here contain a versatile 1-hydroxybicyclo[n.1.0]-
alkane13 or conjugated enone14 moiety. Thus, the reaction may
find wide applicability for synthesizing a variety of N-
heterocyclic compounds.
Experimental Section
General Methods. Infrared spectra were reported in cm-1
.
1H
NMR spectra were measured at 300 MHz with CDCl3 as a solvent at
ambient temperature and the chemical shifts were described in parts
per million downfield from tetramethylsilane (δ ) 0 ppm) or based on
residual CHCl3 (δ ) 7.26 ppm) as an internal standard. 13C NMR
spectra were recorded at 75 MHz with CDCl3 as a solvent and
referenced to the central line of the solvent (δ ) 77.0 ppm). The
coupling constants (J) are reported in hertz. All experiments were
conducted under argon atmosphere in oven-dried flasks. Tetrahydro-
furan and diethyl ether were distilled from sodium benzophenone ketyl
immediately prior to use. The procedure for preparation of the starting
materials 4, 5, 8, 9, 10, 11, 12, 13, 14, 15, 16 and 17 and their
spectroscopic data were given in Supporting Information.
Synthesis of Quinolone, [1,2-a]Indole and [1,2-a]Pyrrole Deriva-
tives by Titanium-Mediated INAS or Tandem INAS-ICA Reaction.
Procedure for the Reaction of Olefinic Substrates. To a stirred
solution of N-allyl- or N-homoallyl compound 4, 8, 9, 11, 12, 16, or
17 (1.0 mmol) and Ti(O-i-Pr)4 (385 µL, 1.30 mmol) in ether (6-8
mL) was added i-PrMgCl or i-PrMgBr (1.1-1.8 M in ether, 2.60 mmol)
at -78 °C. The resulting mixture was gradually warmed to room
temperature over 2-2.5 h. After addition of tetrahydrofuran (5 mL)
and water (2.4 mL), the mixture was stirred for 30 min. The organic
layer was separated, and the residue was washed with ether (2 × 10
mL). The combined organic layers were dried over anhydrous
magnesium sulfate and concentrated in Vacuo. The crude product was
purified by column chromatography on silica gel to give the N-
heterocyclic compound having a cyclopropanol moiety.
(E)-1-Benzyl-1,2,3,4-tetrahydro-3-heptylidene-4-quinolone (7b):
1H NMR (300 MHz) δ 8.04 (dd, J ) 1.7, 7.9, 1H), 7.31 (m, 6H), 6.87
(t, J ) 7.7, 1H), 6.75 (t, J ) 7.4, 1H), 6.68 (d, J ) 8.4, 1H), 4.59 (s,
2H), 4.22 (s, 2H), 2.06 (q, J ) 7.4, 2H), 1.43 (m, 2H), 1.25 (m, 6H),
0.87 (t, J ) 6.8, 3H). Anal. Calcd for C23H27NO: C, 82.84; H, 8.16;
N, 4.20. Found: C, 82.11; H, 8.35; N, 4.59.
(E)-4-Trimethylsilylmethyleneindolo[1,2-a]pyrrolidin-3-one (en-
try 3, Table 1): yellow crystalline (recrystallized from hexane); mp
1
125.0-126.5 °C; H NMR (300 MHz) δ 7.77 (d, J ) 8.3, 1H), 7.41
1-Benzylbenzo[b]cyclopropa[3,4]piperidin-4-ol (6a): 1H NMR
(300 MHz) δ 7.62 (dd, J ) 1.7, 7.5, 1H), 7.28 (m, 5H), 7.05 (dt, J )
1,7, 7.8, 1H), 6.83 (t, J ) 7.2, 1H), 6.61 (d, J ) 8.3, 1H), 4.46 (d, J
) 15.5, 1H), 4.22 (d, J ) 15.5, 1H), 3.14 (d, J ) 2.1, 2H), 1.88 (m,
1H), 1.51 (t, J ) 5.5, 1H), 1.23 (dd, J ) 5.0, 9.6, 1H); 13C NMR (75
MHz) δ 142.32, 138.21, 128.83, 128.48, 127.37, 126.91, 126.66, 124.30,
118.00, 112.22, 54.55, 53.27, 45.20, 28.95, 16.47; IR (neat) 3250, 2980,
2950, 1320, 1210. Anal. Calcd for C17H17NO: C, 81.24; H, 6.82; N,
5.57. Found: C, 80.91; H, 7.20; N, 5.78.
Indolo[1,2-a]cyclopropa[3,4]pyrrolidin-3-ol (entry 1, Table 1):
1H NMR (300 MHz) δ 7.54 (dd, J ) 7.5, 1.5, 1H), 7.09 (m, 3H), 6.33
(s, 1H), 4.18 (dd, J ) 10.7, 5.5, 1H), 3.83 (d, J ) 10.7, 1H), 2.90 (br
s, 1H), 2.31 (m, 1H), 1.76 (dd, J ) 9.4, 5.9, 1H), 1.01 (t, J ) 5.4, 1H);
13C NMR (75 MHz) δ 145.46, 132.88, 132.56, 120.97, 120.81, 119.38,
108.98, 91.99, 60.81, 46.38, 28.42, 24.00; IR (neat) 3340, 2960, 1615,
1332, 1225. Anal. Calcd for C12H11NO: C, 77.81; H, 5.99; N, 7.56.
Found: C, 77.62; H, 6.31; N, 7.83.
(m, 2H), 7.20 (m, 1H), 7.15 (s, 1H), 7.11 (t, J ) 2.3, 1H), 4.99 (d, J
) 2.3, 2H), 0.29 (s, 9H); 13C NMR (75 MHz) δ 181.10, 148.91, 135.73,
134.90, 132.10, 131.80, 125.46, 124.14, 121.68, 110.47, 100.86, 45.59,
-1.09; IR (Nujol) 1702, 1630, 1543, 1353. Anal. Calcd for C15H17-
NOSi: C, 70.54; H, 6.71; N, 5.48. Found: C, 70.17; H, 6.98; N, 5.66.
(E)-4-Heptylideneindolo[1,2-a]pyrrolidin-3-one (entry 4, Table
1
1): H NMR (300 MHz) δ 7.76 (d, J ) 8.2, 1H), 7.38 (m, 2H), 7.19
(m, 1H), 7.09 (d, J ) 1.1, 1H), 6.88 (tt, J ) 7.8, 2.2, 1H), 4.91 (d, J
) 2.2, 2H), 2.30 (q, J ) 7.4, 2H), 1.57 (m, 2H), 1.33 (m, 6H), 0.90 (t,
J ) 6.7, 3H); 13C NMR (75 MHz) δ 182.00, 138.10, 137.79, 136.24,
134.57, 131.72, 125.18, 124.03, 121.44, 110.33, 99.96, 43.96, 31.62,
29.83, 29.09, 28.33, 22.53, 14.03; IR (Nujol) 1708, 1652, 1543, 1350.
Anal. Calcd for C18H21NO: C, 80.86; H, 7.92; N, 5.24. Found: C,
80.58; H, 8.20; N, 5.27.
(E)-4-Trimethylsilylmethylenepyrrolo[1,2-a]pyrrolidin-3-one (en-
1
try 7, Table 1): H NMR (300 MHz) δ 7.08 (dd, J ) 2.2, 1.1, 1H),
6.94 (t, J ) 2.2, 1H), 6.86 (dd, J ) 4.4, 1.1, 1H), 6.52 (dd, J ) 4.0,
2.2, 1H), 4.86 (d, J ) 2.3, 2H), 0.22 (s, 9H); 13C NMR (75 MHz) δ
177.69, 149.37, 133.08, 122.15, 116.64, 109.46, 107.79, 47.66, -1.08;
IR (Nujol) 1725, 1660, 1560, 1348. Anal. Calcd for C11H15NOSi: C,
64.35; H, 7.36; N, 6.82. Found: C, 64.15; H, 7.46; N, 6.71.
Indolo[1,2-a]cyclopropa[3,4]piperidin-3-ol (entry 2, Table 1):
yellow crystalline (recrystallized from hexane); mp 52.0-53.5 °C; 1H
NMR (300 MHz) δ 7.56 (dd, J ) 7.0, 1.2, 1H), 7.15 (m, 3H), 6.57 (s,
1H), 4.21 (dt, J ) 13.1, 3.8, 1H), 3.41 (dt, J ) 11.9, 9.2, 1H), 2.81 (br
s, 1H), 2.16 (m, 2H), 1.81 (m, 1H), 1.40 (dd, J ) 10.0, 6.2, 1H), 1.13
(t, J ) 6.3, 1H); 13C NMR (75 MHz) δ 140.64, 136.05, 128.03, 120.63,
(E)-4-Heptylidenepyrrolo[1,2-a]pyrrolidin-3-one (entry 8, Table
1): 1H NMR (300 MHz) δ 7.04 (d, J ) 1.7, 1H), 6.81 (m, 1H), 6.70